Activity record

PGDB_A054464

Assay: viabilityTarget: IKZF3QC: standardized
Activity overview

inhibition = 40-50 %

TargetIKZF3
Cell lineCFPAC-1
Concentration10 nM
Time96 h
Assay / Readout% Inhibition / viability
Assay IDPGDB_AS000245
PatentWO2025162225A1
QC statusstandardized
Evidence details

Compound, assay context, and source

Compound

2D structure for PGDB_C024235
Compound IDPGDB_C024235
CompoundGT-10301
Source record IDPGDB_C024235
InChIKeyFEVUORYHDRIFPF-UHFFFAOYSA-N

Assay context

Assay IDPGDB_AS000245
Assay familyviability
Assay systemcell_based
Readout% Inhibition
Concentration10 nM
Treatment time96 h
Detection target% Cell viability
TargetIKZF3
E3Not specified
Cell lineCFPAC-1
OrganismHomo sapiens

Source evidence

Patent IDWO2025162225A1
Compound location

GT-10301

GT-10301 enlarged structureGT-10301 location on patent page 32
Activity table
Page 156 · table single